Acute Myelogenous Leukemia
Juvaris wins innovation research grant for acute myelogenous leukemia vaccine development
Published in Medical Letter on the CDC and FDA, October 29th, 2006
Juvaris BioTherapeutics, Inc., announced award of a 1-year phase I small business innovation research (SBIR) grant from the U.S. National Cancer Institute (NCI) of the U.S. National Institutes of Health in collaboration with Dr. David Claxton at Pennsylvania State College of Medicine, Pennsylvania State University's medical school, for the development of a therapeutic vaccine approach for the treatment of acute myelogenous leukemia (AML).
Juvaris' vaccine technology will be tested in rodent tumor models to evaluate the impact on leukemia using an antigen-specific immunotherapeutic AML vaccine (JuvaVax). The SBIR grant application was supported by preclinical data...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Food Safety
Method determines sulfonamide residues in aquacultured fish - Genetics & Genomics
Genomes have been determined for 13 Crimean-Congo hemorrhagic fever virus strains - HIV/AIDS Screening
Test showed high sensitivity, specificity for HIV antibody in blood and oral fluid - Morphogenesis
Decapentaplegic head capsule mutations disrupt Drosophila ventral head morphogenesis - Pertussis
Mixture model analyzes diagnostic cut-off for pertussis antibody levels - Addiction Medicine
Central excitatory effects of intravenous cocaine are related to Na+ channels - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
